- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Henan Lingrui Pharmaceutical Co Ltd (600285)
The Henan Lingrui Pharmaceutical share price today is 18.98, view SS 600285 stock exchange data. Track the latest Henan Lingrui Pharmaceutical share price with real-time updates on 600285 stock performance including market cap, day range, 52-week range and dividend yield. Access 600285 charts, earnings dates and analyst estimates to support your investment decisions.
18.98
+0.29(+1.55%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
18.67
18.99
52 wk Range
18.51
23.65
High dividend Yield
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
18.6718.99
52 wk Range
18.5123.65
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.80%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(5.80%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
600285 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
26.20
Upside
+38.04%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High shareholder yield
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 26.20
(+38.04% Upside)
Earnings
Latest Release
13-08-2026
EPS / Forecast
0.44 / --
Revenue / Forecast
1.02B / --
Compare 600285 to Peers and Sector
Metrics to compare | 600285 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600285PeersSector | |
|---|---|---|---|---|
P/E Ratio | 13.8x | 21.9x | −0.3x | |
PEG Ratio | −14.69 | 1.26 | 0.00 | |
Price/Book | 3.3x | 2.2x | 2.6x | |
Price / LTM Sales | 2.8x | 3.4x | 3.0x | |
Upside (Analyst Target) | 38.0% | 34.3% | 58.5% | |
Fair Value Upside | Unlock | 14.3% | 7.1% | Unlock |
Henan Lingrui Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of drugs in China. It operates through Medical and Healthcare Division; and Others segments. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, and tinctures, etc. for various indications, including orthopedic, cardiovascular, cerebrovascular, dermatology, pediatrics, respiratory, nutritional supplements, and anesthesiology. Its products include Tongluoqutong plasters, Peiyuantongnao capsules, Danlutongdu tablets, stomachache free tablets, and Shenqi Hypoglycemic capsules. The company also engages in industrial and real estate investment; technology research and development; ecological agriculture; and high-tech activities. Henan Lingrui Pharmaceutical Co., Ltd. was founded in 1992 and is headquartered in Xinyang, China.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Henan Lingrui Pharmaceutical (600285) Share Price Today?
The Henan Lingrui Pharmaceutical share price today is 18.98.
What is the current Henan Lingrui Pharmaceutical (600285) share price and day range?
As of 06-10-2026, the Henan Lingrui Pharmaceutical share price is 18.98, with a previous close of 18.98. The share price has ranged from 18.67 to 18.99 today, while the 52-week range spans from 18.51 to 23.65.
What Is the Henan Lingrui Pharmaceutical Market Cap?
As of today, Henan Lingrui Pharmaceutical market cap is 10.76B.
Does Henan Lingrui Pharmaceutical Pay Dividends? What's The Current Dividend Yield?
The Henan Lingrui Pharmaceutical dividend yield is 5.8%.
What Is the Henan Lingrui Pharmaceutical (600285) Share Price Target?
The average 12-month share price target for Henan Lingrui Pharmaceutical is 26.20, with a high estimate of 26.2 and a low estimate of 26.2. 2 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and +38.04% Upside potential.
What Is Henan Lingrui Pharmaceutical's Earnings Per Share (TTM)?
The Henan Lingrui Pharmaceutical EPS (TTM) is 1.37.
When Is the Next Henan Lingrui Pharmaceutical Earnings Date?
Henan Lingrui Pharmaceutical will release its next earnings report on 30-10-2026.
From a Technical Analysis Perspective, Is 600285 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
What Stock Exchange Does Henan Lingrui Pharmaceutical Trade On?
Henan Lingrui Pharmaceutical is listed and trades on the Shanghai Stock Exchange.
What Is the Stock Symbol for Henan Lingrui Pharmaceutical?
The stock symbol for Henan Lingrui Pharmaceutical is "600285."
How Many Times Has Henan Lingrui Pharmaceutical Stock Split?
Henan Lingrui Pharmaceutical has split 4 times.
How Many Employees Does Henan Lingrui Pharmaceutical Have?
Henan Lingrui Pharmaceutical has 2789 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.